Skip to content

A Study on Adults with Anal Fissures to Compare the Pain-Relieving Effects of Ayurvedic Pichha Basti and Lignocaine Ointment

Comparative effect of Piccha Basti and Lignocaine Oint. in pain management of Parikartika w.s.r. to anal fissure. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088881
Enrollment
60
Registered
2025-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

None listed

Sponsors

Seema Rawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a confirmed diagnosis of Parikartika (anal fissure) will be eligible for inclusion in the study. Individuals aged between 18 and 65 years, of either gender, will be considered. Participation will be voluntary, and informed consent must be obtained from all subjects. The study will include patients who are working and living under stressful conditions, as well as those who follow a lifestyle and dietary pattern known to aggravate Pitta and Vata doshas (prakopak aahar and vihaar).

Exclusion criteria

Exclusion criteria: Patients with anorectal conditions other than Parikartika, such as hemorrhoids, abscesses, or colorectal cancer, will be excluded from the study. Pregnant and breastfeeding individuals will not be included due to the potential effects of the interventions on these conditions. Patients with known allergies or hypersensitivity to any components of Pichha Basti or Lignocaine will also be excluded. Additionally, individuals with severe cognitive impairment or mental health disorders that may hinder their ability to provide informed consent or comply with study procedures will not be eligible. Those with a history of drug or alcohol abuse that could interfere with adherence to the study protocol will likewise be excluded.

Design outcomes

Primary

MeasureTime frame
Relief in subjectives parameters like- Pain Intensity (VAS Score) Burning Sensation (Daah) Itching (Kandu) Pain Duration after Defecation Treatment Tolerance Healing Progress (Clinical/Endoscopic Evaluation) Bleeding Control (Asrik Shraav) Sphincter Tone Assessment Inflammation Levels (e.g., CRP)Timepoint: Day 0, Day 7, Day 14, Day 21

Secondary

MeasureTime frame
Relief in subjectives parameters like- Pain Intensity (VAS Score) Burning Sensation (Daah) Itching (Kandu) Pain Duration after Defecation Treatment Tolerance Healing Progress (Clinical/Endoscopic Evaluation) Bleeding Control (Asrik Shraav) Sphincter Tone Assessment Inflammation Levels (e.g., CRP)Timepoint: Day 21

Countries

India

Contacts

Public ContactSeema Rawat

Uttaranchal Ayurvedic College & Hospital Dehradun

drimranpatel@gmail.com9370106316

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026